News

Vaccine proves effective against hepatitis E
Chinese scientists have developed a promising vaccine against hepatitis E that they say safely protects most adults from the infectious disease, which kills many people in countries with poor sanitation.

McDonald's customers warned of hep A case
A case of hepatitis A has been confirmed in a food handler at a McDonald's restaurant in Lethbridge, Alta.

Restaurant customers warned of hep-A
Diners who ate at a Lethbridge McDonalds last month are being warned after a case of hepatitis A was found in a food handler.

BioWatch: Emergent wins more federal backing for anthrax vaccine
Emergent BioSolutions has won up to $28.7 million from the National Institute of Allergy and Infectious Diseases to help develop its next-generation anthrax vaccine candidate.

Drug abuse and it's link to HIV/AIDS and other diseases
What Is HIV/AIDS?

Animal rights groups face off with scientists over fate of chimps
Reporting from Albuquerque Ever since the first of their number arrived in New Mexico half a century ago as test subjects in the fledgling U.S. space program, nearly 200 government-owned chimpanzees were routinely injected with viruses and used to test...

HPV vaccine can stop cervical cancer in girls -- and now some recommend it for boys
Parents may have heard of the vaccine commonly recommended for their daughters to prevent cervical cancer. The shots are now also available to their sons to prevent genital warts and possibly to avoid transmitting the virus to girls.

Abbott Receives FDA Approval For First Automated Molecular Test For Assessing Hepatitis B Treatment
Abbott (NYSE: ABT) announced it has received approval from the U.S. Food and Drug Administration (FDA) to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis B virus (HBV) in a patient's blood. It is the first and only approved test capable of automating HBV viral load testing from sample extraction to final results. The Abbott RealTime HBV assay, based on ...

Abbott gets US FDA nod for Abbott RealTime HBV assay, automated molecular test for assessing hep B treatment
Abbott has received approval from the US Food and Drug Administration (FDA) to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis B virus (HBV) in a patient's blood.

Marci’s Medicare Answers September 2010: Prostate cancer screenings… emergency ambulance calls… Hepatitis B shots… and ...
Dear Marci, Does Medicare cover screenings for prostate cancer? — Sven Dear Sven, Yes. Medicare covers one prostate screening per year (every 12 months) for men age 50 and older. Prostate cancer screenings can detect prostate cancer, which affects one in six men, in its early stages.